The incidence of esophageal cancer (EC) is on the rise. With the distinct subtypes of adenocarcinoma and squamous cell carcinoma comes specific risk factors, and as a result, people of certain regions of the world can be more prone to a subtype. For example, squamous cell carcinoma of the esophagus has the highest incidence in eastern Africa and eastern Asia, with smoking being a major risk factor, whereas adenocarcinoma is more prevalent in North America and western Europe, with gastroesophageal reflux disease being a leading risk factor. With that being said, adenocarcinoma and squamous cell carcinoma have similar and unfortunately poor survival rates, partly because EC is prone to early metastasis given that the esophagus does not have a serosa, as well as the superficial nature of its lymphatics compared with the rest of the gastrointestinal tract. This makes early detection of the utmost importance, and certain patients have been shown to have the benefit of screening/surveillance endoscopies, including those with Barrett's esophagus, lye-induced/caustic strictures, tylosis, and Peutz-Jeghers syndrome. Until treatments significantly improve, identifying EC at the earliest stage will have the best success for patient outcomes, and further elucidation of its pathogenesis and risk factors may lead to identifying other high-risk groups that should be screened.
Kroupa R. Kroupa R. Klin Onkol. 2013;26 Suppl:S17-21. doi: 10.14735/amko2013s17. Klin Onkol. 2013. PMID: 24325158 Review. Czech.
Shaheen N, Ransohoff DF. Shaheen N, et al. JAMA. 2002 Apr 17;287(15):1972-81. doi: 10.1001/jama.287.15.1972. JAMA. 2002. PMID: 11960540 Review.
Bollschweiler E, Hölscher AH. Bollschweiler E, et al. Onkologie. 2001 Apr;24(2):180-4. doi: 10.1159/000050312. Onkologie. 2001. PMID: 11441301 German.
von Rahden BH, Stein HJ, Siewert JR. von Rahden BH, et al. Curr Oncol Rep. 2003 May;5(3):203-9. doi: 10.1007/s11912-003-0111-x. Curr Oncol Rep. 2003. PMID: 12667417 Review.
Spechler SJ. Spechler SJ. Rev Gastroenterol Disord. 2002;2 Suppl 2:S25-9. Rev Gastroenterol Disord. 2002. PMID: 12478241 Review.
Feng Y, Lv M, Zeng S, Zeng H, Yu J. Feng Y, et al. J Radiat Res. 2024 Jul 22;65(4):433-449. doi: 10.1093/jrr/rrae040. J Radiat Res. 2024. PMID: 38842165 Free PMC article.
Lu C, Chen Z, Lu H, Zhao K. Lu C, et al. J Clin Biochem Nutr. 2024 May;74(3):213-220. doi: 10.3164/jcbn.22-138. Epub 2023 Nov 23. J Clin Biochem Nutr. 2024. PMID: 38799145 Free PMC article.
Wang HF, Zhou XF, Zhang QM, Wu JQ, Hou JH, Xu XL, Li XM, Liu YL. Wang HF, et al. Cancer Control. 2024 Jan-Dec;31:10732748241257142. doi: 10.1177/10732748241257142. Cancer Control. 2024. PMID: 38769028 Free PMC article.
Tian J, Hu X, Zhang X. Tian J, et al. Oncol Res. 2024 Apr 23;32(5):925-931. doi: 10.32604/or.2023.042447. eCollection 2024. Oncol Res. 2024. PMID: 38686057 Free PMC article.
van Nieuw Amerongen MP, de Grooth HJ, Veerman GL, Ziesemer KA, van Berge Henegouwen MI, Tuinman PR. van Nieuw Amerongen MP, et al. Ann Surg Oncol. 2024 May;31(5):3471-3472. doi: 10.1245/s10434-024-15089-z. Epub 2024 Mar 7. Ann Surg Oncol. 2024. PMID: 38451389 Free PMC article. No abstract available.